AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1943183
Drug: Stanford solution
RxNorm normalized name: Stangard
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stanford solution
Trial: 27037996
Drug: 70 mL
RxNorm normalized name: ALCOHOL 70 mL TOPICAL SWAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70 mL of concentrated nitrate-rich beetroot juice (BR)
Trial: 24897504
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no paracetamol)
Trial: 30539492
Drug: Locoregional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Locoregional treatment (LRT)
Trial: 20697801
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (NACT) with docetaxel, doxorubicin and cyclophosphamide (TAC)
Trial: 24833235
Drug: Rivaroxaban vs
RxNorm normalized name: Rivaroxaban
DrugBank: Rivaroxaban (DB06228)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rivaroxaban vs Warfarin (no AAD)
Trial: 1897307
Drug: 0.025 mg
RxNorm normalized name: lisuride 0.025 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.025 mg Pasteur BCG by intradermal injection
Trial: 25596270
Drug: Subcutaneous bortezomib
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous bortezomib
Trial: 31707149
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 325 mg
Trial: 15508780
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment
Trial: 20454891
Drug: High-dose B-complex
RxNorm normalized name: vitamin B complex
DrugBank: Dexpanthenol (DB09357)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-dose B-complex vitamin and mineral supplement (Berocca(R))
Trial: 22707560
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (9 g/day; 1.6 g eicosapentaenoic acid and 1.1 g docosahexaenoic acid)
Trial: 8743406
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg naproxen
Trial: 25566930
Drug: Edoxaban 15
RxNorm normalized name: edoxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 15 mg (on-dialysis)
Trial: 17997115
Drug: 200 mcg
RxNorm normalized name: CrM 200 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mcg salbutamol via pMDI+ Volumatic
Trial: 17997115
Drug: 400 mcg
RxNorm normalized name: Biotin 400 MCG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mcg salbutamol via pMDI+ Volumatic
Trial: 29168741
Drug: Tyrosine 150
RxNorm normalized name: TYROSINE 150 ug / PANTOTHENIC ACID 15 mg / METHYLCOBALAMIN 1 mg / CHOLECALCIFEROL 1200 [USP'U] / THIAMINE 1 mg / LEVOMEFOLATE CALCIUM 6 mg / RIBOFLAVIN 5'-PHOSPHATE 3 mg / PYRIDOXAL 5-PHOSPHATE 10 mg / NIACINAMIDE 5 mg / ASCORBIC ACID 85 ug ORAL TABLET [Neuro 110]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tyrosine 150 mg/kg
Trial: 12887139
Drug: Caffeine 300
RxNorm normalized name: caffeine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 300 mg/70 kg
Trial: 19454870
Drug: Lacosamide 600
RxNorm normalized name: Lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lacosamide 600 mg/d
Trial: 19454870
Drug: Lacosamide 400
RxNorm normalized name: Lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lacosamide 400 mg/d
Trial: 3931661
Drug: Pethidine 1
RxNorm normalized name: Pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine 1 mg kg‐1
Trial: 788143
Drug: Meningococcal group
RxNorm normalized name: meningococcal group B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal group A polysaccharide vaccine
Trial: 333906
Drug: Porcine intestinal
RxNorm normalized name: porcine intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porcine intestinal heparin (2 units/ml)
Trial: 16083201
Drug: Sham traction
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham traction with routine conservative treatment
Trial: 11491207
Drug: Pioglitazone HCl
RxNorm normalized name: PIOGLITAZONE HCL
DrugBank: Pioglitazone (DB01132)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pioglitazone HCl 30 mg once daily
Trial: 23278328
Drug: Infusion group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion group
Trial: 6470965
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily (1500 mg of salicylate)
Trial: 1400933
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (GnRHa) buserelin stopped on the same day as HMG treatment
Trial: 20646350
Drug: Sublingual allergoid
RxNorm normalized name: Coccidioides immitis spherule
DrugBank: Coccidioides immitis spherule (DB11294)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual allergoid immunotherapy (allergoid SLIT)
Trial: 1311351
Drug: sodium stibogluconate
RxNorm normalized name: sodium stibogluconate
DrugBank: Sodium stibogluconate (DB05630)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sodium stibogluconate (20 mg of antimony per kilogram per day intravenously for 20 days)
Trial: 18019665
Drug: Obese individuals
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Obese individuals with insulin resistance
Trial: 31743334
Drug: Anti-OSP antibody
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-OSP antibody responses
Trial: 17985420
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination therapy with MTX and infliximab (Group 4)
Trial: 17985420
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination therapy with MTX, sulfasalazine, and prednisone (Group 3)
Trial: 11896097
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (no further therapy)
Trial: 8512911
Drug: Low level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low level laser therapy (LLLT)
Trial: 1559737
Drug: Ciclopirox olamine
RxNorm normalized name: Ciclopirox Olamine
DrugBank: Ciclopirox (DB01188)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciclopirox olamine lotion
Trial: 20652333
Drug: Landiolol at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol at 30 μg/kg/min
Trial: 1741200
Drug: Intermittent amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent amoxicillin
Trial: 22342538
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate (FF) 50 μg once daily
Trial: 22859563
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment time (OTT) ≥43 days
Trial: 18294310
Drug: Oral alitretinoin
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alitretinoin 30 mg once daily for up to 24 weeks
Trial: 2425671
Drug: Urokinase (UK)
DrugBank: Urokinase (DB00013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urokinase (UK) - 2.83 X 10(5) units by six-hour intravenous drip infusion
Trial: 28274889
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 50,000 IU monthly for 24 months
Trial: 25196897
Drug: Simulated dosing
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated dosing regimens for rFVIIIFc
Trial: 12925474
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of propacetamol 30 mg kg(‐1) and diclofenac 1.1 mg kg(‐1)
Trial: 6884411
Drug: Sulphinpyrazone 800
RxNorm normalized name: Sulphinpyrazone
DrugBank: Sulfinpyrazone (DB01138)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulphinpyrazone 800 mg daily
Trial: 19078834
Drug: Periprocedural abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Periprocedural abciximab treatment
Trial: 28188240
Drug: Lixisenatide 20
RxNorm normalized name: lixisenatide 20 mcg/0.2 mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide 20 μg once daily before breakfast for 24 weeks
Trial: 7669649
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg SDZ IMM 125 daily
Trial: 2257964
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg cimetidine taken twice daily
Trial: 25574800
Drug: Sevoflurane at
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane at 0.5 MAC combined with remifentanil (0.25 to 0.35 μg/kg/min) and cisatracurium (0.03 to 0.04 mg/kg/h)
Trial: 6105024
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose
Trial: 10172545
Drug: Drug supply
RxNorm normalized name: doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug supply and cost sharing system
Trial: 26684635
Drug: Glucosamine sulfate
RxNorm normalized name: Glucosamine Sulfate
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulfate (1500 mg)
Trial: 21221770
Drug: Goserelin 3.6
RxNorm normalized name: goserelin 3.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goserelin 3.6 mg every month
Trial: 1556197
Drug: No Treatment
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No Treatment (NT)
Trial: 15771757
Drug: Ursofalk capsules
RxNorm normalized name: ursodiol Oral Capsule [Ursofalk]
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursofalk capsules
Trial: 1658138
Drug: UK 79300
RxNorm normalized name: UK-390957
DrugBank: UK-390957 (DB11719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK 79300 100 mg every 12 h (group 2)
Trial: 25730407
Drug: Grief-specific music
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grief-specific music therapy in addition to standard care
Trial: 31287580
Drug: Daily full-body
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily full-body application of an emollient with ceramide and amino acids
Trial: 28209746
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus mFOLFOX-6 and bevacizumab (5 mg/kg IV)
Trial: 17513395
Drug: Meal A
RxNorm normalized name: Yardley Oatmeal and Almond Bath Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal A (50 g complete amino acid mixture without extra arginine)
Trial: 31003681
Drug: Gua Sha
RxNorm normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Gua HC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gua Sha therapy (12 sessions, one session per week)
Trial: 24468078
Drug: Aqueous gel
RxNorm normalized name: Sulfacetamide Sodium/Sulfur 10%-5% Topical application Gel/Jelly [ROSULA AQUEOUS GEL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous gel
Trial: 21982723
Drug: Sublingual testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual testosterone 0.75 mg
Trial: 19886836
Drug: Control (single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (single-dose nevirapine)
Trial: 17931758
Drug: Neoadjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant treatment
Trial: 17209220
Drug: Vitamin supplements
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin supplements
Trial: 15516023
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration via mini enema (local administration into the large intestine)
Trial: 12950861
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LR)
Trial: 2657058
Drug: Felodipine 10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 10 mg once daily
Trial: 1746458
Drug: Felodipine 20
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine 20 mg once daily
Trial: 1746458
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg four times daily
Trial: 1746458
Drug: Felodipine 20
RxNorm normalized name: Felodipine
DrugBank: Felodipine (DB01023)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Felodipine 20 mg once daily (follow-up)
Trial: 30513231
Drug: ADHD-specific drugs
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADHD-specific drugs combined with SUD treatments
Trial: 30513231
Drug: Pharmacological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacological treatments for ADHD
Trial: 17724363
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg i.v. pantoprazole infused for 2 minutes
Trial: 9778080
Drug: Double-bolus alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double-bolus alteplase (two 50 mg bolus injections 30 minutes apart)
Trial: 11579072
Drug: Exercise intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exercise intervention (twice weekly Osteofit classes for 10 weeks)
Trial: 25922978
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml bupivacaine with 100 μg of fentanyl and 100 ng naloxone
Trial: 31162856
Drug: Low-dose computed
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose computed tomography (LDCT) screening, 5 annual rounds
Trial: 17939171
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available solid oral dosage pharmaceutical formulations (tablets)
Trial: 31190442
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for pediatric acute myeloid leukemia (AML)
Trial: 20389255
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate 50 mg eq.
Trial: 3892729
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg/d
Trial: 18936569
Drug: Chronic low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic low dose corticosteroid therapy (CCS)
Trial: 11703885
Drug: Tolterodine 2
RxNorm normalized name: tolterodine 2 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine 2 mg bid
Trial: 2107519
Drug: Concurrent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent administration of Haemophilus influenzae type b conjugate vaccine with measles-mumps-rubella vaccine
Trial: 6743785
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral solution
Trial: 15923800
Drug: Overall group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall group (all treatments)
Trial: 9816717
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 6 ml (Group A)
Trial: 8934042
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (estrogen)
Trial: 12611172
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of V2 vasopressin receptor agonist (1‐desamino‐8‐D‐arginin‐vasopressin)
Trial: 29250537
Drug: Halometasone cream
RxNorm normalized name: halometasone
DrugBank: Halometasone (DB13728)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halometasone cream (30g daily for 7-14 days) in Group C
Trial: 19516150
Drug: Nutrition plus
RxNorm normalized name: Liquid Nutrition Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition plus combination of aerobic and strength training (N + CAST)
Trial: 10216540
Drug: PGE1 infusion
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE1 infusion for Group I (pulmonary blood flow increase) and Group III (mixing improvement).
Trial: 10216540
Drug: PGE1 infusion
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE1 infusion for Group II (systemic blood flow increase).
Trial: 26342560
Drug: Droxidopa 600
RxNorm normalized name: Droxidopa
DrugBank: Droxidopa (DB06262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Droxidopa 600 mg/day for 8 weeks
Trial: 29310631
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g CTE with 50 g sucrose in 400 mL of water
Trial: 23701526
Drug: XR-NTX 380
RxNorm normalized name: NTx-265
DrugBank: NTx-265 (DB05649)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: XR-NTX 380 mg
Trial: 12771037
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA), 4 g daily for 3 months
Trial: 10543808
Drug: L. rhamnosus
RxNorm normalized name: L. reuteri/L. rhamnosus 1 billion cell ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. rhamnosus 19070‐2
Trial: 22119181
Drug: Mindful awareness
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mindful awareness in body-oriented therapy (MABT)
Trial: 23558369
Drug: Sham block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham block (30 mL 0.9% NaCl)
Trial: 19920766
Drug: Clarithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (500 mg daily for 2 weeks)
Trial: 8791947
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg t.d.s. for the first 2 weeks
Trial: 1514724
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg meperidine and 50 mg hydroxyzine
Trial: 2439815
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg
Trial: 30302901
Drug: Intralesional pentoxifylline
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional pentoxifylline (PTX) injection
Trial: 27759579
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (600 mg/day)
Trial: 15850466
Drug: Lamivudine, 100
RxNorm normalized name: LamiVUDine, 100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine, 100 mg, qd, for 12 months
Trial: 26712409
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of diluted tincture of opium (DTO)
Trial: 30923094
Drug: Bortezomib-dexamethasone induction
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bortezomib-dexamethasone induction treatment
Trial: 14739855
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment (n=9) at a continuous rate of >=1.5 microU/kg/min to maintain euglycemia (serum glucose 100‐140 microg/dL)
Trial: 14739855
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment (n=9)
Trial: 25596138
Drug: BUD pMDI
RxNorm normalized name: Clove buds
DrugBank: Clove (DB10672)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUD pMDI 2 × 160 μg bid